TickerFacts.

NRC Health (NRC): Operating Cash Flow

Annual figures by period end, from SEC filings.

$26.45M
Year ended 2025-12-31
$29.51M
Trailing 12 months to 2026-06-30
-10.0%
3-year compound annual growth
-8.2%
5-year compound annual growth
+1.9%
10-year compound annual growth
$46.34M2009-12-31: $13.67M2010-12-31: $14.60M2011-12-31: $18.48M2012-12-31: $19.13M2013-12-31: $19.32M2014-12-31: $26.20M2015-12-31: $21.89M2016-12-31: $26.84M2017-12-31: $28.09M2018-12-31: $39.85M2019-12-31: $40.92M2020-12-31: $40.64M2021-12-31: $46.34M2022-12-31: $36.27M2023-12-31: $38.11M2024-12-31: $34.62M2025-12-31: $26.45M$26.45M
2009-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$26.45M-23.6%2026-03-05, From 2025-01-01
2024-12-31$34.62M-9.2%2026-03-05, From 2024-01-01
2023-12-31$38.11M+5.1%2026-03-05, From 2023-01-01
2022-12-31$36.27M-21.7%2025-03-17, From 2022-01-01
2021-12-31$46.34M+14.0%2024-02-27, From 2021-01-01
2020-12-31$40.64M-0.7%2023-03-03, From 2020-01-01
2019-12-31$40.92M+2.7%2022-03-04, From 2019-01-01
2018-12-31$39.85M+41.9%2021-03-05, From 2018-01-01
2017-12-31$28.09M+4.6%2020-03-06, From 2017-01-01
2016-12-31$26.84M+22.6%2019-03-08, From 2016-01-01
2015-12-31$21.89M-16.5%2018-03-14, From 2015-01-01
2014-12-31$26.20M+35.6%2017-03-03, From 2014-01-01
2013-12-31$19.32M+1.0%2016-03-04, From 2013-01-01
2012-12-31$19.13M+3.5%2015-03-04, From 2012-01-01
2011-12-31$18.48M+26.6%2014-03-04, From 2011-01-01
2010-12-31$14.60M+6.9%2013-03-01, From 2010-01-01
2009-12-31$13.67Mn/a2012-03-01, From 2009-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
NRC Health (NRC)2025-12-31$26.45M-23.6%
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
OmniAb, Inc. (OABI)2025-12-31-$36.45Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.87Mn/m
Medpace Holdings, Inc. (MEDP)2025-12-31$713.22M+17.1%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.33Mn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27$737.65M+0.4%
Incyte Corp (INCY)2025-12-31$1.41B+321.5%
Absci Corp (ABSI)2025-12-31-$92.92Mn/m

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗